Archive
Year
Volume(Issue)
Issues
Journal Article
Download
فارسی Version
Tremelimumab as second-line or thirdline treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial
LANCET ONCOLOGY
Year:
Volume:
Issue:
Pages:
Citations:
Views:
Downloads:
more
View 77